Neuroprotective Properties of Green Tea (Camellia sinensis) in Parkinson’s Disease: A Review
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroprotective Properties of Green Tea (Camellia sinensis) in Parkinson’s Disease: A Review
Authors
Keywords
-
Journal
MOLECULES
Volume 25, Issue 17, Pages 3926
Publisher
MDPI AG
Online
2020-08-28
DOI
10.3390/molecules25173926
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EGCG ameliorates neuronal and behavioral defects by remodeling gut microbiota and TotM expression in Drosophila models of Parkinson’s disease
- (2020) Yi Xu et al. FASEB JOURNAL
- PGC-1α, Inflammation, and Oxidative Stress: An Integrative View in Metabolism
- (2020) Sergio Rius-Pérez et al. Oxidative Medicine and Cellular Longevity
- A Review of the Role of Green Tea (Camellia sinensis) in Antiphotoaging, Stress Resistance, Neuroprotection, and Autophagy
- (2019) Mani Prasanth et al. Nutrients
- Oxidative Stress: A Key Modulator in Neurodegenerative Diseases
- (2019) Anju Singh et al. MOLECULES
- In vivo, in vitro and pharmacologic models of Parkinson's disease
- (2019) S. Salari et al. PHYSIOLOGICAL RESEARCH
- Function of Green Tea Catechins in the Brain: Epigallocatechin Gallate and its Metabolites
- (2019) Monira Pervin et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Protective Effect of (−)Epigallocatechin-3-gallate on Rotenone-Induced Parkinsonism-like Symptoms in Rats
- (2019) Hsiang-Chien Tseng et al. NEUROTOXICITY RESEARCH
- Bioavailability enhancement of EGCG by structural modification and nano-delivery: A review
- (2019) Wenzhong Dai et al. Journal of Functional Foods
- (-)-Epigallocatechin-3-gallate modulates peripheral immunity in the MPTP-induced mouse model of Parkinson's disease
- (2018) Tingting Zhou et al. Molecular Medicine Reports
- Correction to: Epigallocatechin-3-Gallate Protects and Prevents Paraquat-Induced Oxidative Stress and Neurodegeneration in Knockdown dj-1-β Drosophila melanogaster
- (2018) Daniel A. Martinez-Perez et al. NEUROTOXICITY RESEARCH
- The safety of green tea and green tea extract consumption in adults – Results of a systematic review
- (2018) Jiang Hu et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- α-synuclein oligomers interact with ATP synthase and open the permeability transition pore in Parkinson’s disease
- (2018) Marthe H. R. Ludtmann et al. Nature Communications
- SIRT1/PGC-1α Signaling Promotes Mitochondrial Functional Recovery and Reduces Apoptosis after Intracerebral Hemorrhage in Rats
- (2018) Yang Zhou et al. Frontiers in Molecular Neuroscience
- Alpha-Synuclein: From Early Synaptic Dysfunction to Neurodegeneration
- (2018) Veronica Ghiglieri et al. Frontiers in Neurology
- Global, regional, and national burden of Parkinson's disease, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
- (2018) E. Ray Dorsey et al. LANCET NEUROLOGY
- Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of alzheimer disease and other selected age-related neurodegenerative disorders
- (2017) Fabio Di Domenico et al. FREE RADICAL BIOLOGY AND MEDICINE
- Epidemiology of Parkinson’s disease
- (2017) Ole-Bjørn Tysnes et al. JOURNAL OF NEURAL TRANSMISSION
- Metal chelator EGCG attenuates Fe(III)-induced conformational transition of α-synuclein and protects AS-PC12 cells against Fe(III)-induced death
- (2017) Juan Zhao et al. JOURNAL OF NEUROCHEMISTRY
- Epigallocatechin Gallate Has a Neurorescue Effect in a Mouse Model of Parkinson Disease
- (2017) Qi Xu et al. JOURNAL OF NUTRITION
- The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder
- (2017) Anna Heintz-Buschart et al. MOVEMENT DISORDERS
- Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
- (2017) Zewen Liu et al. Oxidative Medicine and Cellular Longevity
- Oral and nasal microbiota in Parkinson's disease
- (2017) Pedro A.B. Pereira et al. PARKINSONISM & RELATED DISORDERS
- TrkB neurotrophic activities are blocked by α-synuclein, triggering dopaminergic cell death in Parkinson’s disease
- (2017) Seong Su Kang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- (−)-Epigallocatechin-3-gallate (EGCG) inhibits fibrillation, disaggregates amyloid fibrils of α-synuclein, and protects PC12 cells against α-synuclein-induced toxicity
- (2017) Juan Zhao et al. RSC Advances
- Parkinson’s disease: summary of updated NICE guidance
- (2017) Gabriel Rogers et al. BMJ-British Medical Journal
- Parkinson’s disease: summary of updated NICE guidance
- (2017) Gabriel Rogers et al. BMJ-British Medical Journal
- Neuroimaging in pre-motor Parkinson's disease
- (2017) Thomas R. Barber et al. NeuroImage-Clinical
- L-Theanine protects against excess dopamine-induced neurotoxicity in the presence of astrocytes
- (2016) Mika Takeshima et al. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
- The clinical symptoms of Parkinson's disease
- (2016) Sigurlaug Sveinbjornsdottir JOURNAL OF NEUROCHEMISTRY
- Reduction in Autophagy by (-)-Epigallocatechin-3-Gallate (EGCG): a Potential Mechanism of Prevention of Mitochondrial Dysfunction After Subarachnoid Hemorrhage
- (2016) Ying Chen et al. MOLECULAR NEUROBIOLOGY
- Epigallocatechin Gallate (EGCG) Inhibits Alpha-Synuclein Aggregation: A Potential Agent for Parkinson’s Disease
- (2016) Yan Xu et al. NEUROCHEMICAL RESEARCH
- Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation
- (2016) Francesca Magrinelli et al. Parkinsons Disease
- Neuroprotective Activity of (-)-Epigallocatechin Gallate against Lipopolysaccharide-Mediated Cytotoxicity
- (2016) Jin-Biao Liu et al. Journal of Immunology Research
- Neuroprotective Properties of the Standardized Extract fromCamellia sinensis(Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson’s Disease
- (2015) Natália Bitu Pinto et al. Evidence-based Complementary and Alternative Medicine
- Definition of a Molecular Pathway Mediating -Synuclein Neurotoxicity
- (2015) J. Burre et al. JOURNAL OF NEUROSCIENCE
- Colonic bacterial composition in Parkinson's disease
- (2015) Ali Keshavarzian et al. MOVEMENT DISORDERS
- Tea polyphenols alleviate motor impairments, dopaminergic neuronal injury, and cerebral α-synuclein aggregation in MPTP-intoxicated parkinsonian monkeys
- (2015) M. Chen et al. NEUROSCIENCE
- Are cyclooxygenase-2 and nitric oxide involved in the dyskinesia of Parkinson's disease induced by l-DOPA?
- (2015) Mariza Bortolanza et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Beneficial properties of natural phenols: Highlight on protection against pathological conditions associated with amyloid aggregation
- (2014) Massimo Stefani et al. BIOFACTORS
- Functional roles of CREB as a positive regulator in the formation and enhancement of memory
- (2014) Satoshi Kida et al. BRAIN RESEARCH BULLETIN
- How Epigallocatechin Gallate Can Inhibit α-Synuclein Oligomer Toxicityin Vitro
- (2014) Nikolai Lorenzen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EGCG inhibit chemical reactivity of iron through forming an Ngal–EGCG–iron complex
- (2013) Guan-Hu Bao et al. BIOMETALS
- Head injury and risk of Parkinson disease: A systematic review and meta-analysis
- (2013) Siavash Jafari et al. MOVEMENT DISORDERS
- -Synuclein in Parkinson's Disease
- (2013) L. Stefanis Cold Spring Harbor Perspectives in Medicine
- Epigallocatechin-3-gallate suppresses 1-methyl-4-phenyl-pyridine-induced oxidative stress in PC12 cells via the SIRT1/PGC-1α signaling pathway
- (2012) Qinyong Ye et al. BMC Complementary and Alternative Medicine
- α-Synuclein Controls Mitochondrial Calcium Homeostasis by Enhancing Endoplasmic Reticulum-Mitochondria Interactions
- (2012) Tito Calì et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Iron and Neurodegeneration: From Cellular Homeostasis to Disease
- (2012) Liliana Batista-Nascimento et al. Oxidative Medicine and Cellular Longevity
- Increased neuronal glutathione and neuroprotection in GTRAP3-18-deficient mice
- (2011) Koji Aoyama et al. NEUROBIOLOGY OF DISEASE
- Regulation of mitochondrial biogenesis
- (2010) François R. Jornayvaz et al. Essays in Biochemistry
- Inhibition of inducible nitric oxide synthase expression and cell death by (−)-epigallocatechin-3-gallate, a green tea catechin, in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease
- (2010) Ji Seon Kim et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Parkinson's disease symptoms: The patient's perspective
- (2010) Marios Politis et al. MOVEMENT DISORDERS
- Low Dosage of Rasagiline and Epigallocatechin Gallate Synergistically Restored the Nigrostriatal Axis in MPTP-Induced Parkinsonism
- (2010) Lydia Reznichenko et al. Neurodegenerative Diseases
- Protective effect of green tea (-)-epigallocatechin-3-gallate against the monoamine oxidase B enzyme activity increase in adult rat brains
- (2010) Shyh-Mirn Lin et al. NUTRITION
- Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies
- (2010) Ki Sung Kang et al. PLoS One
- EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity
- (2010) Jan Bieschke et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- Fourteen-Week Toxicity Study of Green Tea Extract in Rats and Mice
- (2010) Po C. Chan et al. TOXICOLOGIC PATHOLOGY
- Oxidative Stress and Neurodegenerative Diseases: A Review of Upstream and Downstream Antioxidant Therapeutic Options
- (2009) Bayani Uttara et al. Current Neuropharmacology
- Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
- (2009) K Ray Chaudhuri et al. LANCET NEUROLOGY
- Brain-derived neurotrophic factor in neurodegenerative diseases
- (2009) Chiara Zuccato et al. Nature Reviews Neurology
- Etiology and Pathogenesis of Parkinson Disease
- (2009) Anthony H.V. Schapira NEUROLOGIC CLINICS
- Long-term administration of green tea catechins prevents age-related spatial learning and memory decline in C57BL/6 J mice by regulating hippocampal cyclic amp-response element binding protein signaling cascade
- (2009) Q. Li et al. NEUROSCIENCE
- Akt signal transduction dysfunction in Parkinson's disease
- (2009) Suzanne Timmons et al. NEUROSCIENCE LETTERS
- α-Synuclein is differentially expressed in mitochondria from different rat brain regions and dose-dependently down-regulates complex I activity
- (2009) Guangwei Liu et al. NEUROSCIENCE LETTERS
- A pro-drug of the green tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) prevents differentiated SH-SY5Y cells from toxicity induced by 6-hydroxydopamine
- (2009) Jianfei Chao et al. NEUROSCIENCE LETTERS
- Monoamine oxidase inactivation: From pathophysiology to therapeutics☆
- (2008) Marco Bortolato et al. ADVANCED DRUG DELIVERY REVIEWS
- Green Tea Epigallocatechin 3-Gallate Accumulates in Mitochondria and Displays a Selective Antiapoptotic Effect Against Inducers of Mitochondrial Oxidative Stress in Neurons
- (2008) Emily K. Schroeder et al. ANTIOXIDANTS & REDOX SIGNALING
- Genotoxicity studies on green tea catechin
- (2008) R. Ogura et al. FOOD AND CHEMICAL TOXICOLOGY
- Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain
- (2008) Latha Devi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers
- (2008) Dagmar E Ehrnhoefer et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Protective effect of the green tea component, l-theanine on environmental toxins-induced neuronal cell death
- (2008) Hong-Suk Cho et al. NEUROTOXICOLOGY
- 28-Day oral (gavage) toxicity studies of green tea catechins prepared for beverages in rats
- (2007) Christopher P. Chengelis et al. FOOD AND CHEMICAL TOXICOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started